Both in Pharmaceuticals
Parabilis Medicines vs Dyne Therapeutics
Over the past year PBLS returned −27.5% and DYN returned −6.8%; their daily moves had a correlation of 0.55.
PBLS −27.5% DYN −6.8%Growth of $1, one year, split-adjusted
| Metric | PBLS | DYN |
|---|---|---|
| Price | $26.75 | $16.98 |
| Market cap | $3.30B | $3.17B |
| Today | +0.91% | +0.21% |
| 1 month | −16.2% | +4.7% |
| 6 months | — | −2.5% |
| Year to date | — | −13.2% |
| 1 year | — | −29.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −45239.9% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $1.11B | $685.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 58.2% |
| Short % of float | 9.1% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).